NCT07676279

Brief Summary

This study was conducted to investigate the effect of Cryolipolysis on inflammatory factors in obese postmenopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2025

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

June 24, 2026

Last Update Submit

June 24, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Serum interleukin-6

    Serum interleukin-6 (IL-6) levels were measured from venous blood samples using an enzyme-linked immunosorbent assay (ELISA). IL-6 concentrations were expressed in picograms per milliliter (pg/mL). The normal serum IL-6 level in healthy adults is generally less than 7 pg/mL, higher level indicates inflammatory conditions.

    12 weeks

  • C- Reactive Proteins

    Serum C-reactive protein (CRP) levels were measured from venous blood samples using an immunoturbidimetric assay. CRP concentrations were expressed in milligrams per liter (mg/L). A CRP value below 5 mg/L is generally considered within the normal range. Higher levels indicate inflammatory diseases.

    12 weeks

Secondary Outcomes (9)

  • Body weight

    12 weeks

  • Body mass index

    12 weeks

  • waist circumference

    12 weeks

  • Hip circumference

    12 weeks

  • waist-hip ratio

    12 weeks

  • +4 more secondary outcomes

Study Arms (2)

Cryolipolysis and aerobic exercise group

EXPERIMENTAL

The participants received cryolipolysis sessions on abdominal region (30 minutes/2 sessions per week for 12 weeks) in addition to moderate intensity Aerobic exercises on treadmill for 30 minutes/ 2sessions per week for 12 weeks.

Device: CryolipolysisOther: aerobic exercise

aerobic exercise group

ACTIVE COMPARATOR

The participants received aerobic exercises on treadmill only for 30 minutes/ 2sessions per week for 12 weeks.

Other: aerobic exercise

Interventions

Vacuum controllable head with cold temperature range from -10 to 5°C technique was adjusted according to each patient tolerance, after careful patient sensation examination and vital signs evaluation before and after each session. Cryolipolysis sessions was applied at the hypogastrium area, 5 cm below the umbilicus, for 30 minutes with temperature degree of -5°C using an anti- freezing membrane to avoid cold burn. After starting the device on, the patient was instructed with safety measures to pull the key off if there was any intolerable abnormal sensation.

Cryolipolysis and aerobic exercise group

Participants received moderate intensity aerobic exercises 2 times/week for 12 weeks by using treadmill. Each session took about 30 minutes as the following: 5 minutes warming up exercises by walking on the treadmill by low speed, 20 minutes walking at moderate intensity (70% of the maximal heart rate) and 5 minutes are cooling down by walking on the treadmill with low speed as in warming up (2 sessions/week)

Cryolipolysis and aerobic exercise groupaerobic exercise group

Eligibility Criteria

Age50 Years - 60 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All participants were postmenopausal women.
  • Their ages were ranged from 50 to 60 years old.
  • Body mass index was ranged from 30-40 kg/m2.
  • Waist to hip Ratio was between 0.8-1.0.

You may not qualify if:

  • Systematic disease (uncontrolled hypertension, diabetes mellitus).
  • Thyroid, liver and kidney dysfunctions.
  • Psychiatric disorders.
  • Women received any hormonal therapy or received corticosteroids in the last six months prior to the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nada ElSayed Mohamed

Cairo, Egypt

Location

MeSH Terms

Conditions

Obesity

Interventions

Exercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Samira Swdky, Professor

    Al-Azhar University

    STUDY DIRECTOR
  • Abeer ElDeeb, Professor

    Cairo University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

June 24, 2026

First Posted

June 30, 2026

Study Start

January 1, 2025

Primary Completion

July 15, 2025

Study Completion

July 30, 2025

Last Updated

June 30, 2026

Record last verified: 2026-06

Locations